143 related articles for article (PubMed ID: 11888927)
41. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
[TBL] [Abstract][Full Text] [Related]
42. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
[TBL] [Abstract][Full Text] [Related]
43. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
44. Neurofibromin is actively transported to the nucleus.
Vandenbroucke I; Van Oostveldt P; Coene E; De Paepe A; Messiaen L
FEBS Lett; 2004 Feb; 560(1-3):98-102. PubMed ID: 14988005
[TBL] [Abstract][Full Text] [Related]
45. Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1.
Jang MA; Kim YE; Kim SK; Lee MK; Kim JW; Ki CS
J Hum Genet; 2016 Aug; 61(8):705-9. PubMed ID: 27074763
[TBL] [Abstract][Full Text] [Related]
46. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
47. [Human ribosomal protein S26 inhibits splicing of its own pre-mRNA].
Ivanov AV; Malygin AA; Karpova GG
Mol Biol (Mosk); 2004; 38(4):676-83. PubMed ID: 15456139
[TBL] [Abstract][Full Text] [Related]
48. In NF1, CFTR, PER3, CARS and SYT7, alternatively included exons show higher conservation of surrounding intron sequences than constitutive exons.
Kaufmann D; Kenner O; Nurnberg P; Vogel W; Bartelt B
Eur J Hum Genet; 2004 Feb; 12(2):139-49. PubMed ID: 14560314
[TBL] [Abstract][Full Text] [Related]
49. Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings.
Ahronowitz I; Xin W; Kiely R; Sims K; MacCollin M; Nunes FP
Hum Mutat; 2007 Jan; 28(1):1-12. PubMed ID: 16983642
[TBL] [Abstract][Full Text] [Related]
50. Gene transfer-mediated pre-mRNA segmental trans-splicing as a strategy to deliver intracellular toxins for cancer therapy.
Nakayama K; Pergolizzi RG; Crystal RG
Cancer Res; 2005 Jan; 65(1):254-63. PubMed ID: 15665302
[TBL] [Abstract][Full Text] [Related]
51. NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors.
Metheny LJ; Skuse GR
Exp Cell Res; 1996 Oct; 228(1):44-9. PubMed ID: 8892969
[TBL] [Abstract][Full Text] [Related]
52. Exon trap analysis of a NF1 splice-site mutation in a chronic myelomonocytic leukemia patient.
Ludwig L; Janssen JW; Bartram CR
Leukemia; 1995 May; 9(5):922-4. PubMed ID: 7769857
[TBL] [Abstract][Full Text] [Related]
53. The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.
Pykett MJ; Murphy M; Harnish PR; George DL
Hum Mol Genet; 1994 Apr; 3(4):559-64. PubMed ID: 8069298
[TBL] [Abstract][Full Text] [Related]
54. Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1.
Eisenbarth I; Hoffmeyer S; Kaufmann D; Assum G; Krone W
Arch Dermatol Res; 1995; 287(5):413-6. PubMed ID: 7625848
[TBL] [Abstract][Full Text] [Related]
55. Three novel somatic mutations in the NF2 tumor suppressor gene [g816T>A; g1159A>G; gIVS11-1G>T].
Paz-y-Miño C; Leone PE
Hum Mutat; 2000 May; 15(5):487. PubMed ID: 10790227
[No Abstract] [Full Text] [Related]
56. Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA.
Ars E; Serra E; de la Luna S; Estivill X; Lázaro C
Nucleic Acids Res; 2000 Mar; 28(6):1307-12. PubMed ID: 10684924
[TBL] [Abstract][Full Text] [Related]
57. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.
Ars E; Serra E; García J; Kruyer H; Gaona A; Lázaro C; Estivill X
Hum Mol Genet; 2000 Jan; 9(2):237-47. PubMed ID: 10607834
[TBL] [Abstract][Full Text] [Related]
58. An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues.
Hitotsumatsu T; Kitamoto T; Iwaki T; Fukui M; Tateishi J
J Biochem; 1994 Dec; 116(6):1205-7. PubMed ID: 7706208
[TBL] [Abstract][Full Text] [Related]
59. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
Yoo SJ; Hwang YS
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
[TBL] [Abstract][Full Text] [Related]
60. Exon skipping associated with A-->G transition at +4 of the IVS33 splice donor site of the neurofibromatosis type 1 (NF1) gene.
Hutter P; Antonarakis SE; Delozier-Blanchet CD; Morris MA
Hum Mol Genet; 1994 Apr; 3(4):663-5. PubMed ID: 8069315
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
